Transcranial Magnetic Stimulation (TMS) for Major Depression
Customize your policy alerts
Sign up for lucet Policy 20.5.008 alerts
Get alerted when Policy 20.5.008 changes without checking for updates manually.
Monitor payer policy activity
Policy governing coverage and medical necessity criteria for transcranial magnetic stimulation (TMS) to treat major depressive disorder, including training requirements, eligible patient criteria, treatment protocols, exclusions, and coding guidance for providers and clinics seeking authorization.
Clarified language regarding ECT recommendations.
Add child and adolescent indication from the FDA.
Updated the summary of evidence.
Florida Blue requires age to start at 15 years old.
10 references removed.
3 references added.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.